Environmental fate and chemistry of raloxifene hydrochloride

Environmental Toxicology and Chemistry

Volumn 21, Issue 4, 2002, Pages 729-736

  Teeter, Jerold Scott ^a   Meyerhoff, Roger D ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Biodegradation; Environmental chemistry; Environmental fate; Hydrochloride; Raloxifene

Indexed keywords

ABSORPTION; BIODEGRADATION; HYDROLYSIS; SEWAGE SLUDGE; WASTE TREATMENT;

SELECTIVE ESTROGEN RECEPTOR MODULATORS (SERM);

ENVIRONMENTAL IMPACT;

RALOXIFENE;

ESTROGENIC COMPOUND;

AEROBIC METABOLISM; AQUEOUS SOLUTION; ARTICLE; BIODEGRADATION; DRUG ABSORPTION; DRUG DEGRADATION; DRUG DETERMINATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG HYDROLYSIS; DRUG SOLUBILITY; DRUG STRUCTURE; ENVIRONMENTAL IMPACT; FECES; OSTEOPOROSIS; PH MEASUREMENT; PRIORITY JOURNAL; SEWAGE TREATMENT; SLUDGE; THERMAL ANALYSIS; WAVEFORM;

BIODEGRADATION, ENVIRONMENTAL; ENVIRONMENTAL MONITORING; FECES; HALF-LIFE; HUMANS; HYDROGEN-ION CONCENTRATION; RALOXIFENE; REFUSE DISPOSAL; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SOLUBILITY; WATER POLLUTANTS, CHEMICAL;

EID: 0036556423     PISSN: 07307268     EISSN: None     Source Type: Journal    
DOI: 10.1897/1551-5028(2002)021<0729:EFACOR>2.0.CO;2     Document Type: Article

References (12)

1. Ashworth LE. 1998. Focus on raloxifene: A selective estrogen receptor modulator for prevention of osteoporosis in postmenopausal women. Formulary 33:305-317.
2. Willhite SL, Goebel SR, Scoggin JA. 1998. Raloxifene provides an alternative for osteoporosis prevention. Ann Pharmacother 32:834-837.
3. Lufkin EG, Whitaker MD, Nickelsen T, Argueta R, Caplan RH, Knickerbocker RK, Riggs BL. 1998. Treatment of established postmenopausal osteoporosis with raloxifene: A randomized trial. J Bone Miner Res 13:1747-1754.
4. Compston JE. 1998. Selective oestrogen receptor modulators: Potential therapeutic applications. Clin Endocrinol 48:389-391.
5. 14C-labeled raloxifene in humans. Pharm Res 12:S372.
6. Forgue ST, Rudy AC, Geiser J, Basson RP, Knadler MP, Allerheiligen SR, Henry PD. 1997. Interconversion pharmacokinetics of the selective estrogen receptor modulator raloxifene HCl. Pharm Res 14:S605.
7. Forgue ST, Rudy AC, Knadler MP, Basson RP, Nelson JE, Henry DP, Allerheiligen SR. 1996. Raloxifene pharmacokinetics in healthy, postmenopausal women. Pharm Res 13:S429.
8. Eirkson C, Harrass MC, Osbourne CM, Sayre PG, Zeeman M. 1987. Water solubility. In Environmental Assessment Technical Assistance Handbook, Vol 3.01. PB87-175345. U.S. Food and Drug Administration, Washington DC, pp 1-11.
9. U.S. Environmental Protection Agency. 1982. Partition coefficient CG-1400. In Chemical Fate Test Guidelines. EPA 560/682-003. National Technical Information Service, Springfield, VA.
10. Eirkson C, Harrass MC, Osbourne CM, Sayre PG, Zeeman M. 1987. Hydrolysis. In Environmental Assessment Technical Assistance Handbook, Vol 3.09. PB87-175345. U.S. Food and Drug Administration, Washington, DC, pp 1-6.
11. Lyman WJ. 1990. Adsorption coefficient for soils and sediments. In Lyman WJ, Reehl WF, Rosenblatt DH, eds, Handbook of Chemical Property Estimation Methods. American Chemical Society, Washington, DC, pp 4.1-4.33.
12. Eirkson C, Harrass MC, Osbourne CM, Sayre PG, Zeeman M. 1987. Aerobic biodegradation in water. In Environmental Assessment Technical Assistance Handbook, Vol 3.11. PB87-175345. U.S. Food and Drug Administration, Washington, DC, pp 1-18.